NCT01910662 arm group f81e58e9f18039c3d0995996c4d31546 [clinicaltrials_resource:NCT01910662/arm-group/f81e58e9f18039c3d0995996c4d31546]
NCT01910662 arm group f81e58e9f18039c3d0995996c4d31546 [clinicaltrials_resource:NCT01910662/arm-group/f81e58e9f18039c3d0995996c4d31546]
Bio2RDF identifier
NCT01910662/arm-group/f81e58e9f18039c3d0995996c4d31546
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 1e58e9f18039c3d0995996c4d31546
description [clinicaltrials_vocabulary:description]
Subjects in the Part B Cohort ...... n induration of 6 mm or more).
identifier
clinicaltrials_resource:NCT01910662/arm-group/f81e58e9f18039c3d0995996c4d31546
title
NCT01910662 arm group f81e58e9f18039c3d0995996c4d31546
@en
type
label
NCT01910662 arm group f81e58e9 ...... e58e9f18039c3d0995996c4d31546]
@en